PTGX   $41.7  2.58% Market Closed After Close 41.65 -0.12%

Protagonist Therapeutics Inc
Total Cash 564.00M
totalCashPerShare 9.575
EBITDA 153.21M
Total Debt 10.97M
quickRatio 13.598
currentRatio 13.731
Total Revenue 319.12M
debtToEquity 2.027
Revenue/Share 5.278
ROA 0.20351
ROE 0.40688
grossProfits
freeCashflow 143.73M
operatingCashflow 231.54M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.48009998
operatingMargins -9.30958
profitMargins 0.53257
enterpriseValue 2.15B
forwardPE -31.733332
floatShares 43.68M
sharesOutstanding 58.90M
sharesShort 3.00M
sharesShortPriorMonth 3.23M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.07%
Short Ratio help_outline 4.19%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 9.212
Price To Book help_outline 5.17
earningsQuarterlyGrowth
netIncomeToCommon 169.95M
trailingEps 2.72%
forwardEps -1.50%
enterpriseToEbitda 14.04
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.61 3Q 2024
institutionsCount 298
lastUpdated Nov. 7, 2024, 2:30 a.m.